Ritipenem
Ritipenem is a penem class antimicrobial agent. Ritipenem is manufactured by Tanabe Seiyaku in the ritipenem acoxil prodrug form, which can be taken orally . It is not FDA approved in the United States as of 2008.
![]() | |
| Identifiers | |
|---|---|
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C10H12N2O6S |
| Molar mass | 288.27 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
References
- Eiland III EH, Gatlin D (October 2008). "Forecast of antibiotic development in an era of increasing bacterial resistance". Journal of Pharmacy Practice. 21 (5): 313–8. doi:10.1177/0897190008318499.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
